Brief: Aeglea Biotherapeutics Announces Name Change To Spyre Therapeutics

Spyre Therapeutics

27/11/2023 15:21

Nov 27 (Reuters) - Aeglea Bio Therapeutics Inc  AGLE.O :
    * AEGLEA BIOTHERAPEUTICS ANNOUNCES NAME CHANGE TO SPYRE
THERAPEUTICS, APPOINTS CEO AND ADDITIONAL DIRECTORS, AND EXPANDS
LEADERSHIP TEAM TO DEVELOP NEXT-GENERATION THERAPEUTIC
COMBINATIONS FOR THE TREATMENT OF IBD
    * AEGLEA BIO THERAPEUTICS INC - COMPANY WILL BEGIN TRADING
ON
NASDAQ UNDER TRADING SYMBOL "SYRE" EFFECTIVE NOVEMBER 28, 2023
    * AEGLEA BIO THERAPEUTICS INC -  CAMERON TURTLE APPOINTED AS
CHIEF
EXECUTIVE OFFICER AND MEMBER OF BOARD OF DIRECTORS
    * AEGLEA BIO THERAPEUTICS: $205 MILLION OF CASH, CASH
EQUIVALENTS,
MARKETABLE SECURITIES, RESTRICTED CASH AS OF SEPTEMBER 30, WITH
EXPECTED RUNWAY INTO 2026

Source text for Eikon:  ID:nPn61Nptma 
Further company coverage:  AGLE.O 

 ((Reuters.Briefs@thomsonreuters.com;))